Cite
HARVARD Citation
Cerva, C. et al. (2016). Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. Clinical microbiology and infection. pp. 946.e1-946.e8. [Online].